Skip to content
Use caution Drug recall · FDA · Published January 7, 2021

American Health Packaging Recalls Nitrofurantoin Capsules Due to Dissolution Failure

American Health Packaging is recalling Nitrofurantoin Capsules USP 100 mg due to failed dissolution specifications. Check your lot number and expiration date.

🇺🇸 FDA recall #D-0232-2021DrugAmerican Health Packaging ›
Take action

Contact the company

Recalling firmAmerican Health Packaging2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

American Health Packaging has recalled Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, because the product failed dissolution specifications. This means the capsules may not release the medication properly in the body, potentially reducing its effectiveness for treating urinary tract infections. The recall affects 1,948 cartons distributed nationwide. Read more at govinfonow.com/recall/36555-american-health-packaging-recalls-nitrofurantoin-capsules-due-to-dissolution-failure.

Source Summary by GovInfoNow · govinfonow.com/recall/36555-american-health-packaging-recalls-nitrofurantoin-capsules-due-to-dissolution-failure · Updated October 11, 2026 · FDA enforcement record: FDA #D-0232-2021

Cite this page

“American Health Packaging Recalls Nitrofurantoin Capsules Due to Dissolution Failure.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/36555-american-health-packaging-recalls-nitrofurantoin-capsules-due-to-dissolution-failure. Based on FDA recall #D-0232-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0232-2021%22&limit=1).

The FDA announced on Jan. 7, 2021, that American Health Packaging voluntarily recalled Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg due to failed dissolution specifications. The recall affects 1,948 cartons distributed nationwide.

How to tell if you have it

  • Brand: American Health Packaging
  • Product: Nitrofurantoin Capsules 100 mg
  • NDC Carton: 68084-446-01
  • NDC Blister Card: 68084- 446-11
  • Lot #: 193757
  • Expiration Date: Exp 1/31/2022

The hazard

The capsules failed to meet dissolution specifications, which could result in the drug not releasing properly. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Other recent recalls of similar products include Golden State NIACIN Extended-Release Tablets Recall (May 29, 2026), Mylan Recalls Amnesteem Isotretinoin Capsules Due to Dissolution Failure (Feb. 24, 2026), and Inventia Chlorthalidone Recall (Sept. 3, 2026).

How to tell if you have this one

Look for Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, in cartons containing 100 capsules (10 capsules x 10 blister cards). Check the NDC Carton number 68084-446-01 or NDC Blister Card number 68084-446-11. The specific recalled lot is #193757 with an expiration date of 1/31/2022.

  • Brand
    American Health Packaging
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your Nitrofurantoin capsules match the brand, lot number #193757, and expiration date of 1/31/2022.

  2. Contact Your Pharmacist

    If you have the recalled product, contact your pharmacy or healthcare provider to discuss replacing it with a different manufacturer's product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Jan 7, 202112. FDA classified it Class II: Jan 15, 202123. Published in FDA’s Enforcement Report: Jan 27, 202134. FDA terminated the recall: Aug 3, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other American Health Packaging recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0232-2021 (January 7, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0232-2021 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA